The final day of tax selling made it irresistible.
By Paul Price of Market Shadows
Sometimes the best new idea is to increase your position in old ideas. We added 38 new shares of Quest Diagnostics (DGX) @ $53.36 and 80 extra shares of Bio Reference Labs (BRLI) @ $25.42 to our Virtual Value Portfolio this afternoon.
Both stocks appear to be suffering from year-end tax-related sell-off today. We’ll get a quick rebate on DGX as it goes ex-dividend for 30-cents a share this Friday.
The $4,061 combined purchases from our cash reserve fund.
Our portfolio looks to be finishing out 2013 at a new all-time record. See details of all our closed-out and open holdings by clicking here.
